Dr. Ole Dammann

Dr. Ole Dammann serves as Managing Director at Klinische Forschung Beteiligungsgesellschaft mbH and kfgnPratia GmbH, along with the role of Chief Executive Officer at Pratia Germany. Their involvement extends to angel investing with Springboard Health Angels and mentoring at Startup Creasphere and Startupbootcamp. Previously, Dr. Dammann held various positions in finance and project management at Fresenius Medical Care, Freudenberg Chemical Specialties, and Klüber Lubrication, along with academic contributions as a Lecturer at Frankfurt School of Finance & Management. Dr. Dammann's educational background includes a PhD in Business Administration from the University of Mannheim, complemented by studies at Stanford University and The London School of Economics.